These 10 Stocks Moved the Market This Week, Here’s Why

Page 2 of 10

9. Hims & Hers Health, Inc. (NYSE:HIMS)

Hims & Hers Health saw its share prices jump by 27.29 percent week-on-week, ending Friday’s trading at $51.96 versus the $40.82 close a week earlier, as investors cheered its impressive earnings performance and expectations of more clinched partnerships for the rest of the year.

In its latest earnings release, Hims & Hers Health, Inc. (NYSE:HIMS) said that its net income expanded by 346 percent to $49.5 million from the $11.1 million registered in the same period last year, while revenues soared by 111 percent to $586 million from $278.2 million year-on-year.

The company said that its strong performance underpinned its updated 2025 guidance, with full-year revenues expected to settle between $2.3 billion and $2.4 billion, and the second quarter to end at $530 million to $550 million.

In recent news, Hims & Hers Health, Inc. (NYSE:HIMS) clinched a long-term deal with Novo Nordisk to jointly market the latter’s blockbuster weight loss drug, Wegovy, which now allows users to access NovoCare Pharmacy directly through its platform.

Apart from Novo Nordisk, the company said it is set to ink more deals with other companies soon.

Page 2 of 10